| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |